Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 68001-646

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68001-646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 01)

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)
This text provides information about the percentage reduction in CPS rate using Divalproex Sodium Delayed-Release Tablets compared to a placebo. It shows the percentage of patients with improvement, no change, or worsening in their condition.*
FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)
This is an evaluation of the reduction in CPS rate based on different percentages, including 100%, 75%, 50%, and 2%. The text also mentions two types of tablets related to high dose and low dose Divalproex Sodium. Additionally, it refers to the percentage of patients in the evaluation.*
FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)
This text contains information about two medications: Placebo and Divalproex sodium (extended-release tablets). It also mentions a numerical value of p=0.006 along with a list of numbers.*
FDA Label Image

Label Divalproex Sodium Er Tablets Usp 250 mg 100 Counts (546b07bd 7dba 49c9 8caf 7914600d4d19 06)

Label Divalproex Sodium Er Tablets Usp 250 mg 100 Counts (546b07bd 7dba 49c9 8caf 7914600d4d19 06)
This text is a product description for Divalproex Sodium Extended-Release Tablets. Each film-coated tablet contains 250mg of Divalproex Sodium, USP equivalent to valproic acid. The product is intended for once-daily dosing and comes in a bottle with 100 tablets. The tablets should be stored at 20°C to 25°C (68°F to 77°F) in a tight, light-resistant container. The pharmacist is advised to dispense a Medication Guide to each patient along with the tablets. Additionally, the text emphasizes keeping the medication out of reach of children and not accepting the product if the seal over the bottle opening is broken or missing.*
FDA Label Image

Label Divalproex Sodium Er Tablets Usp 500 mg 100 Counts (546b07bd 7dba 49c9 8caf 7914600d4d19 07)

Label Divalproex Sodium Er Tablets Usp 500 mg 100 Counts (546b07bd 7dba 49c9 8caf 7914600d4d19 07)
This is a description for an extended-release tablet containing Divalproex Sodium, equivalent to valproic acid 500mg. The usual dosage instructions are provided in the package insert. It is recommended to store the tablets in a USP tight, light-resistant container at a temperature range of 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). It is emphasized to keep the medication out of reach of children. Additionally, the tablets are for once-daily dosing, and pharmacists should provide the accompanying Medication Guide to each patient. The tablets are manufactured by UNICHEM LABORATORIES LTD in India for BluePoint Laboratories.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.